[go: up one dir, main page]

FI982722L - Diagnostinen menetelmä - Google Patents

Diagnostinen menetelmä Download PDF

Info

Publication number
FI982722L
FI982722L FI982722A FI982722A FI982722L FI 982722 L FI982722 L FI 982722L FI 982722 A FI982722 A FI 982722A FI 982722 A FI982722 A FI 982722A FI 982722 L FI982722 L FI 982722L
Authority
FI
Finland
Prior art keywords
diagnostic method
diagnostic
Prior art date
Application number
FI982722A
Other languages
English (en)
Swedish (sv)
Other versions
FI982722A0 (fi
FI108301B (fi
Inventor
Tapio Visakorpi
Jorma Isola
Nina Nupponen
Ovod Volodymyr
Original Assignee
Finnish Immunotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Finnish Immunotechnology Ltd filed Critical Finnish Immunotechnology Ltd
Priority to FI982722A priority Critical patent/FI108301B/fi
Publication of FI982722A0 publication Critical patent/FI982722A0/fi
Priority to EP99963608A priority patent/EP1151144A2/en
Priority to PCT/FI1999/001039 priority patent/WO2000036144A2/en
Priority to AU19849/00A priority patent/AU1984900A/en
Publication of FI982722L publication Critical patent/FI982722L/fi
Priority to US09/878,328 priority patent/US20030022174A1/en
Application granted granted Critical
Publication of FI108301B publication Critical patent/FI108301B/fi

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI982722A 1998-12-16 1998-12-16 Diagnostinen menetelmä FI108301B (fi)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FI982722A FI108301B (fi) 1998-12-16 1998-12-16 Diagnostinen menetelmä
EP99963608A EP1151144A2 (en) 1998-12-16 1999-12-15 Cancer diagnostic method using p40 subunit of eif3
PCT/FI1999/001039 WO2000036144A2 (en) 1998-12-16 1999-12-15 Cancer diagnostic method using p40 subunit of eif3
AU19849/00A AU1984900A (en) 1998-12-16 1999-12-15 Diagnostic method
US09/878,328 US20030022174A1 (en) 1998-12-16 2001-06-12 Cancer diagnostic method using P40 subunit of EIF3

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI982722 1998-12-16
FI982722A FI108301B (fi) 1998-12-16 1998-12-16 Diagnostinen menetelmä

Publications (3)

Publication Number Publication Date
FI982722A0 FI982722A0 (fi) 1998-12-16
FI982722L true FI982722L (fi) 2000-06-17
FI108301B FI108301B (fi) 2001-12-31

Family

ID=8553128

Family Applications (1)

Application Number Title Priority Date Filing Date
FI982722A FI108301B (fi) 1998-12-16 1998-12-16 Diagnostinen menetelmä

Country Status (5)

Country Link
US (1) US20030022174A1 (fi)
EP (1) EP1151144A2 (fi)
AU (1) AU1984900A (fi)
FI (1) FI108301B (fi)
WO (1) WO2000036144A2 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002255445A1 (en) * 2001-12-05 2003-06-23 Genzyme Corporation Diagnosis of cancer using eif3 as a marker
US8309302B2 (en) * 2005-07-15 2012-11-13 Abbott Laboratories Reagents and methods for processing biological samples
CN103667424A (zh) * 2012-08-29 2014-03-26 上海吉凯基因化学技术有限公司 人eif3h基因的用途及其相关药物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658730A (en) * 1994-12-23 1997-08-19 Ctrc Research Foundation Methods of human prostate cancer diagnosis

Also Published As

Publication number Publication date
AU1984900A (en) 2000-07-03
WO2000036144A2 (en) 2000-06-22
FI982722A0 (fi) 1998-12-16
EP1151144A2 (en) 2001-11-07
FI108301B (fi) 2001-12-31
WO2000036144A3 (en) 2000-09-21
US20030022174A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
DE69938817D1 (de) Erstellungsverfahren
ID26007A (id) Proses karbonilasi
DE69835302D1 (de) Tintenbehälternachfüllsystem
DE69812868D1 (de) Flanschreformierungsanlage
DE69928148D1 (de) Wasserskimmer
ID23316A (id) Proses karbonilasi
DE69906880D1 (de) Bilderzeugungsverfahren
DE69901852D1 (de) Perfluorodioxolen
DE69928710D1 (de) Geldscheinentstaplungsvorrichtung
NO20003164L (no) Ultralydmetode
DE69827358D1 (de) Weglenkungsverfahren
FI980488A (fi) Uusi diagnostinen menetelmä
ID28840A (id) Pengujian
DE69809804D1 (de) Notlaufgeländereifen
FI990382A0 (fi) Uusi diagnostinen menetelmä
ID23306A (id) Turunan-turunan di- atau triaza-spiro dekana
FI981431A0 (fi) Mittausmenetelmä
FI982722A0 (fi) Diagnostinen menetelmä
NO994317L (no) Diagnosemetode
FI981242A0 (fi) Menetelmä kefalokuvien ottamiseksi
FI980950A0 (fi) Uusi diagnostinen menetelmä
DE59911641D1 (de) Radaufhängungs-tester
ATA126298A (de) Verpuffungsklappe
FI980206A0 (fi) Remhaollare foer lastbaerare
FI980165A0 (fi) Diagnostiskt foerfarande